article · Neurology

Comparative Efficacy and Safety of CGRP Monoclonal Antibodies and Oral Gepants for Migraine Prevention: Evidence from Randomized Controlled Trials and Network Meta-analysis (P10-15.014)

Sharath Chandra Anne
Shradha Kakde
Ahmed Harb
Meghana Chennupati
A Mansour
R Khan
Meghnath Kakde
H Ramteke

2026Al-Azhar University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Migraine and Headache Studies
Autoimmune Neurological Disorders and Treatments
Parkinson's Disease Mechanisms and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1212/wnl.0000000000216798

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.